McGill University Health Centre ( Site 0204)

Montreal, Quebec H4A 3J1

1 studies enrolling now · 3 studies all time

What they study most

Coronavirus Disease (COVID-19), Non-small Cell Lung Cancer (NSCLC), Triple Negative Breast Neoplasms

Studies at this site

• A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) — Recruiting now
• Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009) — Running, not enrolling
• Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) — Completed